BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

August 16, 2017 5:44 PM UTC

In vitro studies identified a vinyl ketone peptide-based inhibitor of Trypanosoma rhodesain, a cysteine protease from T. brucei rhodesiense, that could help treat African trypanosomiasis. Chemical syn...

BCIQ Target Profiles

Trypanosoma rhodesain